Ann M. Daus
Corporate Officer/Principal bij Laureate Biopharmaceutical Services, Inc.
Profiel
Ann M.
Daus is currently the Vice President-Quality at Laureate Biopharmaceutical Services, Inc. She has a graduate and doctorate degree from Rutgers State University of New Jersey and an undergraduate degree from Millersville University.
Actieve functies van Ann M. Daus
| Bedrijven | Functie | Begin |
|---|---|---|
Laureate Biopharmaceutical Services, Inc.
 Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 16-03-2011 |
Opleiding van Ann M. Daus
| Rutgers State University of New Jersey | Doctorate Degree |
| Millersville University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Laureate Biopharmaceutical Services, Inc.
Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ. | Health Technology |
